vTv Therapeutics Inc
VTVT
NASDAQ
Biotechnology
$30.12
USD
-0.73 (-2.37%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $125.18M
Volume 74.8K
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
XGN | Exagen Inc | $160.42M | - | +20.8% | - | |
VTVT | vTv Therapeutics Inc | $139.32M | 61.86 | +216600.0% | - | |
EQ | Equillium Inc | $139.10M | - | - | - | |
INDP | Indaptus Therapeutics Inc | $134.76M | - | - | - | |
UNCY | Unicycive Therapeutics Inc | $133.90M | - | - | - | |
SPRB | Spruce Biosciences, Inc | $127.16M | - | - | - | |
GNLX | Genelux Corp | $121.97M | - | - | - | |
ANIX | Anixa Biosciences Inc | $111.94M | - | - | - | |
COYA | Coya Therapeutics Inc | $108.84M | - | +115.4% | - | |
CUE | Cue Biopharma Inc | $106.27M | - | +309.6% | - |
Top Peer by Growth
vTv Therapeutics Inc
+216600.0% YoY Revenue
Lowest P/E Ratio
vTv Therapeutics Inc
55.59x P/E
Best 1-Year Return
Insight Molecular Diagnostics Inc
+51.4% Return